In this real‐life study of survival with checkpoint inhibitor therapy for multiple tumour entities, we observed an independent association of pre‐treatment comorbidities, CRP and eosinophil count, and occurrence of irAE with improved overall survival. This evidence concerns the gene CRP and neoplasm.